MAFFDA Class 3 · implantable

Stent, Coronary

Device family · Unknown

Automated profile from regulatory + adverse-event registries · AI-reviewed · expert clinical sign-off in progress — not yet independently verified.
FDA clearances
867
Manufacturers
15
Flagged signals
17
Adverse-event reports
10,632

Code matrix

FDA product codeMAF
Device classClass 3
Regulation
GMDN— (crosswalk pending)
ImplantableYes
Life-sustainingNo

Adverse-event signals

Public · always free

MAUDE disproportionality (PRR), flagged where PRR ≥ 2, χ² ≥ 4, count ≥ 3.

Event typeYearReportsPRRχ²
Death20101446.8587
Death2010324.346
Death20065012.4517
Death20074410.9390
Death2010299.6217
Death201739.215
Death2010129.078
Death2005317.7175
Death2008307.4162
Death2017116.647
Death2019284.265
Death202063.69
Death2009103.314
Death201653.05
Death2020192.821
Death2010182.717
Death2011152.17

Device-level recall linkage pending an FDA-recalls product-code re-ingest. Class 3 family · 10,632 total adverse-event reports.

Manufacturer landscape

ManufacturerClearancesLatestConcern
Boston Scientific Scimed, Inc.3022016
Medtronic, Ireland1432022
Abbott Vascular, Inc.902022
Boston Scientific Corp892026
Abbott Vascular752023
Medinol, Ltd.412020
Cordis Corp.412004
BIOTRONIK AG252026
CELONOVA BIOSCIENCES, INC.192021
Advanced Cardiovascular Systems, Inc.172010
Medtronic Vascular92001
Cook, Inc.72002
Poseidon Medical, Inc.62020
Medtronics Interventional Vascular21998
Biotronik GmbH & Co. KG12005

Concern score lights up where a maker maps to a scored entity (depth fast-follow).

Recent FDA clearances

PRO-Kinetic Energy Coronary Stent System · Biotronik AGPMA · 2026-04-15
PRO-Kinetic Energy Coronary Stent System · Biotronik AGPMA · 2026-04-01
REBEL PLATINUM CHROMIUM CORONARY STENT SYSTEM MONORAIL AND OVER THE WIRE · Boston Scientific CorpPMA · 2026-03-10
PRO-Kinetic Energy Coronary Stent System · Biotronik AGPMA · 2025-07-10
PRO-Kinetic Energy Coronary Stent System · Biotronik AGPMA · 2025-02-14
PRO-Kinetic Energy Coronary Stent System · Biotronik AGPMA · 2024-05-17
PRO-Kinetic Energy Coronary Stent System · Biotronik AGPMA · 2024-04-24
PRO-Kinetic Energy Coronary Stent System · Biotronik AGPMA · 2024-03-26
REBEL Platinum Chromium Coronary Stent System Monorail and Over the Wire · Boston Scientific CorpPMA · 2023-12-12
PRO-KINETIC ENERGY CORONARY STENT SYSTEM · Biotronik AGPMA · 2023-08-16
PRO-Kinetic Energy Coronary Stent System · Biotronik AGPMA · 2023-08-07
REBEL Platinum Chromium Coronary Stent System Monorail and Over the Wire · Boston Scientific CorpPMA · 2023-07-27
MULTI-LINK VISION® RX Coronary Stent System, MULTI-LINK MINI VISION® RX Coronary Stent System · Abbott VascularPMA · 2023-06-14
MULTI-LINK VISION RX Coronary Stent System, MULTI-LINK MINI VISION Coronary Stent System · Abbott VascularPMA · 2023-06-12
PRO-Kinetic Energy Coronary Stent System · Biotronik AGPMA · 2023-03-03
REBEL Platinum Chromium Coronary Stent System · Boston Scientific CorpPMA · 2023-03-02
REBEL Platinum Chromium Coronary Stent System Monorail and Over the Wire · Boston Scientific CorpPMA · 2022-11-15
MULTI-LINK RX ULTRA™ Coronary Stent System · Abbott Vascular, Inc.PMA · 2022-09-07
MULTI-LINK VISION™ RX Coronary Stent System, MULTI-LINK VISION™ RX 2.75 mm Coronary Stent System, MULTI-LINK MINI VISION · Abbott VascularPMA · 2022-09-07
PRO-Kinetic Energy Coronary Stent System · Biotronik AGPMA · 2022-07-27
Integrity Coronary Stent Systems · Medtronic, IrelandPMA · 2022-07-15
Integrity Rapid Exchange Coronary Stent System, Integrity Over The Wire Coronary Stent System · Medtronic, IrelandPMA · 2022-04-19
REBEL Platinum Chromium Coronary Stent System (Monorail and Over-The-Wire) · Boston Scientific CorpPMA · 2022-02-25
Integrity Coronary Stent System · Medtronic, IrelandPMA · 2022-01-27
Integrity Coronary Stent System RX and OTW · Medtronic, IrelandPMA · 2021-12-14

Sources: FDA 510(k)/PMA · openFDA MAUDE · FDA device classification · MedevIQ manufacturer-canonical. Registry data, AI-reviewed; expert clinical sign-off in progress.

Early access

MedevIQ is in private preview.

We're onboarding hospitals, manufacturers, regulators and research teams in waves. Tell us how you'd use MedevIQ and we'll get back within a working week.

We'll reply within a working week.

Access by invitation while v1 finalizes.